Navigation Links
New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
Date:5/9/2008

A include fatigue, decreased hemoglobin, osteoporosis and may contribute to shortening life expectancy by affecting major organ systems. After 10 years, less than 50 percent of patients can continue to work or function normally on a daily basis. RA affects more than 21 million people worldwide with approximately 1.3 million adults affected in the United States.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our website: http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at http://www.RocheExchange.com.

All trademarks used or mentioned in this release are protected by law.

Contacts: Ginny Valenze

Roche

Office: 973-562-2783

virginia.valenze@roche.com

(1) ACR20, ACR50 and ACR70 represent the percentage of reduction (20%, 50%

or 70%) in certain RA symptoms and measures the number of tender and

swollen joints, pain, patient's and physician's global assessments and

certain
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 16, 2013  Alere Inc. (NYSE: ALR ), ... their health at home through the merger of rapid diagnostics ... per share on its Series B Convertible Perpetual Preferred Stock ... to holders of record of Series B stock at the ... payment will cover the amount of all dividends accrued from ...
(Date:5/16/2013)... 2013 OrthoView PSL will allow ... access the widely-used OrthoView digital templating software via the ... to get started. OrthoView, the leading independent ... years, is dedicated to enabling orthopaedic surgeons in hospitals ... when printed film is unavailable. Over 5,000 orthopaedic surgeons ...
(Date:5/16/2013)... , May 16, 2013  A new survey ... living with vulvar and vaginal atrophy (VVA) are either ... or are simply dissatisfied with the therapies available. The ... ,s VI ews of Treatment Options for Menopausal ... to the treatment of VVA, including lack of knowledge, ...
Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 3
... The National Association of Drug Diversion Investigators ... between law enforcement, healthcare professionals, state regulatory agencies ... of drug diversion – today released the following ... Substance Abuse and Mental Health Services Administration (SAMHSA) ...
... Sept. 12, 2011 A revolutionary new imaging device ... - - the VivoSight® Optical Coherence Tomography ... in the U.S. for the first time.  The VivoSight® ... instantly, providing additional information which will allow them to ...
Cached Medicine Technology:Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy 2Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy 3Revolutionary Device for Use in Detecting Non-Melanoma Skin Cancer in Real Time, Alleviates Patient Stress, Can Reduce Invasive Biopsy 4
(Date:5/18/2013)... (PRWEB) May 18, 2013 The product liability ... lawsuits on behalf of consumers nationwide who have sustained ... Shape-Ups toning shoes. These cases are all part of MDL ... Skechers lawsuits will be heard in the U.S. ... , Wright & Schulte, LLC specializes in defending the ...
(Date:5/17/2013)... Allen J. Schultz, D.D.S., is making the Laser ... available to residents of San Juan Capistrano. The laser ... than relying on a scalpel to cut the tissue away. ... on tightly defined wavelengths to target the diseased tissue and ... Only about one in every hundred dental professionals is trained ...
(Date:5/17/2013)... 2013 Stryker hip lawsuit claims ... and ABG II Modular-Neck Hip Stem recall continue to move ... According to court documents, a Case Management Conference was ... at which time the Court, among other things, set deadlines ... must submit Fact Sheets to Defendant and Liaison Counsel. ...
(Date:5/17/2013)... N.C., (PRWEB) May 17, 2013 Charlotte’s ... share the spotlight with children served by the Muscular ... event on Tuesday, May 21 at Bank of ... Team is a unique social event that pairs top ... fire fighters, with an “MDA Buddy” (a local child ...
(Date:5/17/2013)... 17, 2013 Parker Waichman LLP ... rights of victims injured by defective medical devices, notes ... said in a May 16, 2013, statement ... and ceramic-on-metal hip replacement products; specifically, the metal liners ... Acetabular Hip System will no longer be available worldwide ...
Breaking Medicine News(10 mins):Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:San Clemente, CA Periodontist, Dr. Allen J. Schultz, Now Provides Laser Gum Disease Treatment to Southern Orange County Periodontal Disease Patients 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 3Health News:MDA Hosts Annual Charlotte Muscle Team Event 2Health News:MDA Hosts Annual Charlotte Muscle Team Event 3Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3
... now widespread, CDC survey finds , MONDAY, April 26 ... have either high blood pressure, high cholesterol or diabetes, ... and other cardiovascular problems, a new government survey finds. ... and Nutrition Examination Survey (NHANES) 1999-2006 shows that 45 ...
... applauds President Obama,s selection of Donald Berwick, M.D., to ... and Medicaid Services. ASTRO looks forward to working closely ... critical healthcare reforms for patients and work toward system ... quality of care patients receive. ASTRO,s highest priority is ...
... Patients can decrease the frequency of Botox Cosmetic injections ... the same wrinkle-smoothing cosmetic benefits, according to new research ... two years of treatment at recommended intervals, patients can ... their Botox treatments by half," said Roger A. Dailey, ...
... type of immune cell are higher in head and neck cancer ... according to researchers at the University of Michigan Comprehensive Cancer Center. ... are most likely to respond to chemotherapy and radiation and allow ... the past, we would give toxic chemotherapy to a patient, look ...
... still time for media to register for the largest ... and publish early results from the International Polar Year ... Conference, WHEN: June 8 to 12, 2010, WHERE: Norway ... Oslo), MEDIA REGISTRATION: http://www.ipy-osc.no/article/2010/1265207747.88 The conference ...
... , ... Finn,s first book on both sides of the Atlantic. This layman,s account of his interest ... their own self worth, regardless of historical, cultural or religious backgrounds, as it strives to ... ...
Cached Medicine News:Health News:Nearly Half of U.S. Adults Have Heart Risk Factors 2Health News:Nearly Half of U.S. Adults Have Heart Risk Factors 3Health News:Botox reduces wrinkles even in less frequent doses 2Health News:Immune cells predict success of head and neck cancer treatment, U-M study finds 2Health News:World's largest polar science conference to take place in Oslo 2Health News:World's largest polar science conference to take place in Oslo 3Health News:Life Coach and Author Thomas Finn's Highly Anticipated Book, 'A Better Tomorrow- Affirmations and Visualizations the Keys to Success,' Debuts June 15 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: